KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Current Assets (2020 - 2025)

Organon has reported Current Assets over the past 6 years, most recently at $4.4 billion for Q4 2025.

  • Quarterly results put Current Assets at $4.4 billion for Q4 2025, changed 0.09% from a year ago — trailing twelve months through Dec 2025 was $4.4 billion (changed 0.09% YoY), and the annual figure for FY2025 was $4.4 billion, changed 0.09%.
  • Current Assets for Q4 2025 was $4.4 billion at Organon, down from $4.7 billion in the prior quarter.
  • Over the last five years, Current Assets for OGN hit a ceiling of $4.8 billion in Q3 2024 and a floor of $3.0 billion in Q1 2021.
  • Median Current Assets over the past 5 years was $4.1 billion (2023), compared with a mean of $4.1 billion.
  • Peak annual rise in Current Assets hit 24.92% in 2022, while the deepest fall reached 17.02% in 2022.
  • Organon's Current Assets stood at $3.8 billion in 2021, then increased by 4.55% to $3.9 billion in 2022, then rose by 14.68% to $4.5 billion in 2023, then decreased by 3.55% to $4.3 billion in 2024, then increased by 0.09% to $4.4 billion in 2025.
  • The last three reported values for Current Assets were $4.4 billion (Q4 2025), $4.7 billion (Q3 2025), and $4.6 billion (Q2 2025) per Business Quant data.